DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy

R Huang, PK Zhou - Signal transduction and targeted therapy, 2021 - nature.com
Genomic instability is the hallmark of various cancers with the increasing accumulation of
DNA damage. The application of radiotherapy and chemotherapy in cancer treatment is …

Dual effect of immune cells within tumour microenvironment: pro-and anti-tumour effects and their triggers

AC Peña-Romero, E Orenes-Piñero - Cancers, 2022 - mdpi.com
Simple Summary The relationship between the immune system and tumours is currently one
of the most studied topics in the field of cancer. Previously, it was thought that a tumour could …

m5C RNA methylation regulators predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma

J Pan, Z Huang, Y Xu - Frontiers in oncology, 2021 - frontiersin.org
RNA methylation is a novel epigenetic modification that can be used to evaluate tumor
prognosis. However, the underlying mechanisms are unclear. This study aimed to …

Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis

Y Huang, L Xia, X Tan, J Zhang, W Zeng, B Tan… - Cellular & Molecular …, 2022 - Springer
Background The pivotal role of long noncoding RNAs (lncRNAs) in cancer immune
responses has been well established. This study was conducted with the aim of exploring …

Pan-immune-inflammation value: a new prognostic index in operative breast cancer

F Lin, LP Zhang, SY Xie, HY Huang, XY Chen… - Frontiers in …, 2022 - frontiersin.org
Background To build a predictive scoring model based on simple immune and inflammatory
parameters to predict postoperative survival in patients with breast cancer. Methods We …

Immunotherapy of targeting MDSCs in tumor microenvironment

H Sui, S Dongye, X Liu, X Xu, L Wang, CQ Jin… - Frontiers in …, 2022 - frontiersin.org
Myeloid-derived suppressor cells (MDSCs) are a group of heterogeneous cells which are
abnormally accumulated during the differentiation of myeloid cells. Immunosuppression is …

[HTML][HTML] RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway

D Zhang, Q Jiang, X Ge, Y Shi, T Ye, Y Mi… - … Journal of Biological …, 2021 - ncbi.nlm.nih.gov
Lung adenocarcinoma (LUAD) is a common type of lung cancer with high frequent
metastasis and a high death rate. However, genes responsible for LUAD metastasis are still …

Immune-checkpoint inhibitors (ICIs) in metastatic colorectal cancer (mCRC) patients beyond microsatellite instability

B Borelli, C Antoniotti, M Carullo, MM Germani… - Cancers, 2022 - mdpi.com
Simple Summary The manuscript reports the most recent literature regarding treatment with
ICIs in mCRC, focusing on dMMR/MSI-H and POLE-mutated tumors, discussing current …

N6-Methyladenosine methylation regulator RBM15 is a potential prognostic biomarker and promotes cell proliferation in pancreatic adenocarcinoma

Z Zhao, Q Ju, J Ji, Y Li, Y Zhao - Frontiers in Molecular Biosciences, 2022 - frontiersin.org
RNA binding motif protein 15 (RBM15) is a key regulatory factor involved in N6-
methyladenosine (m6A) methylation. It has been reported that RBM15 plays an important …

[HTML][HTML] Exosomes in cancer immunoediting and immunotherapy

Y Zhao, L Liu, R Sun, G Cui, S Guo, S Han, Z Li… - Asian journal of …, 2022 - Elsevier
As an important means of communication among cells, exosomes are being studied more
and more widely, especially in the context of cancer immunotherapy. In the phase of tumor …